American Renal Associates (ARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARA | DGX | DVA | EHC | CHE |
| Company | American Renal Associates | Quest Diagnostics Inc | Davita Healthcare Partners Inc | Encompass Health Corp | Chemed Inc |
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | NYSE | NYSE |
| Open | 11.48 | 152.11 | 159.66 | 95.28 | 589.08 |
| High | 11.52 | 152.49 | 161.08 | 95.30 | 590.05 |
| Low | 11.33 | 150.42 | 159.01 | 94.14 | 575.33 |
| Last | 11.52 | 150.79 | 160.69 | 94.50 | 581.55 |
| Change | +0.02 | -0.59 | +1.62 | -0.23 | -3.72 |
| % Change | +0.17% | -0.39% | +1.02% | -0.24% | -0.64% |
| Volume | 9,800 | 500,800 | 391,500 | 426,900 | 95,200 |
| 20-Day Average Volume | 110,105 | 698,270 | 772,295 | 601,330 | 68,360 |
| Previous Close | 11.50 | 151.38 | 159.07 | 94.73 | 585.27 |
| Industry | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 11.47 | 154.05 | 160.84 | 93.87 | 584.43 |
| 20-Day Raw Stochastic | 100.00% | 16.47% | 68.70% | 57.12% | 49.64% |
| 20-Day Relative Strength | 70.89% | 46.29% | 57.54% | 56.40% | 50.74% |
| Weighted Alpha | -7.72 | +21.17 | +76.88 | +45.49 | +9.19 |
| Today's Opinion | 100% Buy | 56% Buy | 88% Buy | 100% Buy | 24% Buy |
| Previous Opinion | 100% Buy | 80% Buy | 88% Buy | 100% Buy | 56% Buy |
| Last Month's Opinion | 72% Buy | 100% Buy | 88% Buy | 100% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.44% since 01/15/21 | -2.59% since 09/27/24 | -1.47% since 09/27/24 | -1.57% since 09/27/24 | -2.92% since 09/27/24 |
| Low | 11.33 on 01/25/21 | 150.42 on 10/04/24 | 156.60 on 10/03/24 | 94.14 on 10/04/24 | 575.33 on 10/04/24 |
| High | 11.52 on 01/25/21 | 155.59 on 09/30/24 | 164.31 on 09/30/24 | 96.83 on 09/30/24 | 603.76 on 10/01/24 |
| 1-Month | |||||
| %Chg | +0.70% since 12/24/20 | -2.96% since 09/04/24 | +6.16% since 09/04/24 | +0.95% since 09/04/24 | -1.18% since 09/04/24 |
| Low | 11.33 on 01/25/21 | 149.52 on 09/11/24 | 148.13 on 09/05/24 | 90.43 on 09/11/24 | 558.41 on 09/11/24 |
| High | 11.52 on 01/25/21 | 157.23 on 09/16/24 | 166.04 on 09/19/24 | 97.56 on 09/26/24 | 605.03 on 09/27/24 |
| 3-Month | |||||
| %Chg | +0.17% since 10/23/20 | +7.02% since 07/03/24 | +16.48% since 07/03/24 | +9.83% since 07/03/24 | +7.69% since 07/03/24 |
| Low | 11.33 on 01/25/21 | 136.99 on 07/09/24 | 131.76 on 08/07/24 | 82.74 on 08/06/24 | 525.36 on 07/10/24 |
| High | 11.52 on 01/25/21 | 159.36 on 09/04/24 | 166.04 on 09/19/24 | 97.56 on 09/26/24 | 605.03 on 09/27/24 |
| 6-Month | |||||
| %Chg | +80.56% since 07/24/20 | +14.67% since 04/04/24 | +20.86% since 04/04/24 | +16.67% since 04/04/24 | -7.59% since 04/04/24 |
| Low | 6.08 on 09/21/20 | 125.42 on 04/18/24 | 125.64 on 04/18/24 | 78.53 on 04/18/24 | 525.36 on 07/10/24 |
| High | 11.98 on 10/06/20 | 159.36 on 09/04/24 | 166.04 on 09/19/24 | 97.56 on 09/26/24 | 632.53 on 04/05/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 397,935 | 16,751,562 | 14,092,511 | 9,514,731 | 8,804,079 |
| Shares Outstanding, K | 34,543 | 111,092 | 87,700 | 100,685 | 15,139 |
| Annual Sales | 822,520,000 | 9,252,000,000 | 12,140,150,000 | 4,801,200,000 | 2,264,420,000 |
| Annual Net Income | -13,790,000 | 854,000,000 | 691,540,000 | 352,000,000 | 272,510,000 |
| Last Quarter Sales | 209,690,000 | 2,397,000,000 | 3,186,720,000 | 1,301,200,000 | 595,880,000 |
| Last Quarter Net Income | -2,690,000 | 229,000,000 | 222,680,000 | 114,100,000 | 70,890,000 |
| 60-Month Beta | 1.11 | 0.89 | 0.87 | 0.88 | 0.44 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.35 on 07/23/24 | 2.59 on 08/06/24 | 1.11 on 08/05/24 | 5.47 on 07/24/24 |
| Latest Earnings Date | 03/15/21 | 10/22/24 | 11/05/24 | 10/24/24 | 10/29/24 |
| Most Recent Dividend | N/A | 0.750 on 10/04/24 | N/A | 0.170 on 10/01/24 | 0.500 on 08/12/24 |
| Next Ex-Dividends Date | N/A | 10/04/24 | N/A | 10/01/24 | 08/12/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.37 | 16.42 | 23.45 | 27.08 |